This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Freie Universitat Berlin, Tentamus Pharma & Med Deutschland Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Veit: Innovator in Viral Production Technology
Introduction
Michael Veit is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of virology, particularly in the production of viruses using advanced cell culture techniques. His innovative approach has implications for both research and therapeutic applications.
Latest Patents
Michael Veit holds a patent for the "Production of viruses in continuously growing epithelial cell lines derived from chicken gut." This patent describes a method for manufacturing viruses in an in vitro cell culture. The process involves providing a cell culture of avian epithelial cells, infecting the cells with virus particles, incubating them, and recovering the produced viruses from the supernatant of the cell culture. This method was patented on December 12, 2018, and represents a significant advancement in viral production technology.
Career Highlights
Throughout his career, Michael Veit has worked with prestigious institutions, including Freie Universität Berlin and Tentamus Pharma & Med Deutschland GmbH. His work has focused on enhancing the efficiency and effectiveness of viral production, which is crucial for vaccine development and other medical applications.
Collaborations
Michael has collaborated with notable colleagues such as Wolfgang Rudy and Chris Tina Höfer. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.
Conclusion
Michael Veit is a pioneering inventor whose work in viral production technology has the potential to impact various fields, including medicine and biotechnology. His innovative methods and collaborations highlight his commitment to advancing scientific knowledge and practical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile